Quality control of the AutoPap screening system employed as a primary screening device: Rapid review of smears coded as no further review

Tumori

Volumn 92, Issue 4, 2006, Pages 276-278

  Bulgaresi, Paolo ^a   Cariaggi, Maria Paola ^a   Troni, Grazia Maria ^a   Ciatto, Stefano ^a  

^a CANCER RESEARCH AND PREVENTION INSTITUTE ISPO   (Italy)

Author keywords

Cervical cancer; Computer assisted reading; Cytology; Screening

Indexed keywords

ADULT; CARCINOMA IN SITU; CLINICAL ASSESSMENT; COLPOSCOPY; CONTROLLED STUDY; CYTOLOGY; DATA BASE; FEMALE; HUMAN; INVASIVE CARCINOMA; MAJOR CLINICAL STUDY; MEDICAL INSTRUMENTATION; MEDICAL SOCIETY; PAPANICOLAOU TEST; QUALITY CONTROL; REVIEW; SCREENING; UTERINE CERVIX CONIZATION; UTERINE CERVIX CYTOLOGY;

EID: 33749519437     PISSN: 03008916     EISSN: None     Source Type: Journal    
DOI: 10.1177/030089160609200402     Document Type: Review

References (14)

1. Patten SF, Lee JSJ, Wilbur DC, Bonfiglio TA, Colgan TJ, Richart RM, Cramer H, Moinuddin S: The AutoPap 300 QC system multicenter clinical trials for use in quality control rescreening of cervical smears. Cancer Cytopathol, 81: 343-347, 1997.
2. Lee JSJ, Kuan L, Oh S, Patten FW, Wilbur DC: A feasibili ty study of the AutoPap system location-guided screening. Acta Cytol, 42: 221-226, 1998.
3. Alasio LM, Alphandery C, Grassi P, Ruggeri M, De Palo G, Pilotti S: Performance of the AutoPap primary screening system in the detection of high risk cases in cervicovaginal smears. Acta Cytol, 45: 704-708, 2001.
4. Tench WD: Validation of AutoPap primary screening system sensitivity and high risk performance. Acta Cytol, 46: 296-302, 2002.
5. Wilbur D, Bonfiglio T, Rutkowski MA, Atkison KM, Richart RM, Lee JS, Patten SF Jr: Sensitivity of the AutoPap 300 QC system for cervical cytology abnormalities. Acta Cytol, 40: 127-132, 1996.
6. Confortini M, Bonardi L, Bulgaresi P, Cariaggi MP, Cecchini S, Ciatto S, Cipparrone I, Galanti L, Maddau C, Matucci M, Rubeca T, Troni GM, Turco P, Zappa M, Carozzi F: A feasibility study of the use of the AutoPap screening system as a primary screening and location-guided rescreening device. Cancer Cytopathology, 99: 129-134, 2003.
7. Dudding N, Hewer EM, Lanucki L, Rice S: Rapid screening: a comparative study. Cytopathology, 12: 235-248, 2001.
8. Solomon D, Davey D, Kurman R, Moriarty A, O'Connor D, Prey M, Raab S, Sherman M, Wilbur D, Wright T Jr, Young N: The 2001 Bethesda System: terminology for reporting results of cervical cytology. JAMA, 287: 2114-2119, 2002.
9. Cecchini S, Iossa A, Bonardi R, Ciatto S, Cariaggi P: Comparing two modalities of management of women with cytologic evidence of squamous or glandular atypia: early repeat cytology or colposcopy. Tumori, 83: 732-734, 1997.
10. ASCUS-LSIL Triage Study (ALTS) Group: A randomized trial on the management of low-grade squamous intraepithelial lesion cytology interpretation. Am J Obstet Gynecol, 188: 1381-1382, 2003.
11. Wilbur DC, Norton MK: The primary screening clinical trials of the TriPath AutoPap System. Epidemiology, 13: S30-S33, 2002.
12. Bibbo M, Hawthorne C: Performance of the AutoPap primary screening system at Jefferson University Hospital. Acta Cytol, 43: 27-29, 1999.
13. Cecchini S, Grazzini G, Iossa A, Bartoli D, Ciatto S: Criteria for adequacy of cervical cytologic sampling. Acta Cytol, 33: 687, 1989.
14. Cecchini S, Grazzini G, Bonardi R, Ciatto S: Quality control in cytologic screening. Acta Cytol, 37: 436, 1993.